Ruth McKernan

Plus aucun poste en cours

Profil

Ruth McKernan was the founder of Alchemab Therapeutics Ltd. founded in 2019, Draig Therapeutics Ltd. founded in 2021 where Dr. McKernan was a Non-Executive Director, and Cumulus Neuroscience Ltd. founded in 2015 where Dr. McKernan was Executive Chairman.
Current jobs include Director at Neusentis, Inc., The Medical Research Council, The Bioindustry Association, and Cerevel Therapeutics, Inc., Member of the Society For Neuroscience and British Pharmacological Society, Trustee at Alzheimer’s Research UK since 2018, and Operating Partner at SV Health Investors LLP since 2018.
Former jobs include Chief Executive Officer at Innovate UK from 2015 to 2018, Independent Director at Cerevel Therapeutics Holdings, Inc. from 2020 to 2024, Director at AstronauTx Ltd., VP & Chief Scientific Officer-Regenerative Medicine at Pfizer Inc., and Member at Cancer Research UK.
Education includes undergraduate and doctorate degrees from the University of London and an undergraduate degree from King's College London.

Postes actifs de Ruth McKernan

Sociétés	Poste	Début
Neusentis, Inc.	Directeur/Membre du Conseil	18/10/2011
The Medical Research Council	Directeur/Membre du Conseil	-
Society For Neuroscience	Corporate Officer/Principal	-
British Pharmacological Society	Corporate Officer/Principal	-
Alzheimer’s Research UK	Directeur/Membre du Conseil	01/01/2018
SV Health Investors LLP	Private Equity Investor	01/04/2018
The Bioindustry Association	Directeur/Membre du Conseil	-
Cerevel Therapeutics, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Ruth McKernan

Sociétés	Poste	Fin
Cumulus Neuroscience Ltd.	Fondateur	08/01/2026
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░	-
░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-